SHU-508

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSHU-508
Drug Alias Namegalactose + palmitic acidEchoscopeLevovistSHU-508-ASHTA-508 +[6
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionUltrasonography enhancers
TargetsNot applicable
Therapy Area/IndicationsVentricular Dysfunction, LeftNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsVentricular Dysfunction, LeftNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeV09
Related LinksKEGG